Reuters -- Germany’s Merck KGaA still sees its application for European approval of multiple sclerosis pill cladribine on track, while regulatory clearance in the United States remains uncertain.
Reuters -- Germany’s Merck KGaA still sees its application for European approval of multiple sclerosis pill cladribine on track, while regulatory clearance in the United States remains uncertain.
